FOXM1 and lip and oral cavity carcinoma: Our results further suggest that the overexpression of FOXM1 protein by cisplatin makes it difficult to overcome drug resistance to cisplatin and causes resistance to paclitaxel, which can potentially attenuate the effectiveness of combination chemotherapeutics on oral cancer.